A PREDICTION MODEL FOR CHRONIC HEART FAILURE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

A PREDICTION MODEL FOR CHRONIC HEART FAILURE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Introduction. One of the common adverse complications that may occur in patients with type 2 diabetes mellitus (T2DM) after acute myocardial infarction (AMI) is the development and progression of chronic heart failure (CHF). Currently, it remains relevant to study biomarkers of energy homeostasis th...

Full description

Saved in:

Bibliographic Details
Main Authors:	Mariia Yu. Koteliukh, Svitlana I. Bokova, Nadiia V. Demikhova, Nataliia D. Lantukhova
Format:	Article
Language:	English
Published:	State Institution of Science «Research and Practical Center of Preventive and Clinical Medicine» State Administrative Department 2025-04-01
Series:	Клінічна та профілактична медицина
Subjects:	energy metabolism heart failure myocardial infarction type 2 diabetes mellitus
Online Access:	https://cp-medical.com/index.php/journal/article/view/540
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Chronic heart failure
by: J. A. Ker
Published: (2015-09-01)

PHARMACOECONOMIC ASPECTS OF EPLERENONE USAGE IN CHRONIC HEART FAILURE
by: Yu. M. Lopatin, et al.
Published: (2015-08-01)

Predictors of acute heart failure in patients during the acute period of Q-wave myocardial infarction
by: V. D. Syvolap, et al.
Published: (2019-04-01)

Comorbidity in acute heart failure complicating myocardial infarction
by: M. V. Zykov, et al.
Published: (2020-08-01)

Short-term and long-term prognosis in patients with Q-myocardial infarction complicated by acute heart failure with hyperglycemia
by: V. D. Syvolap, et al.
Published: (2019-10-01)

Effects of angiotensin receptor–neprilysin inhibition on myocardial energy metabolism and prognosis in patients with acute myocardial infarction complicated by heart failure
by: Caiming Cheng, et al.
Published: (2025-08-01)

The effect of empagliflozin on the development of chronic heart failure after myocardial infarction according to a 12-month prospective study
by: Alexey A. Nekrasov, et al.
Published: (2019-10-01)

HEART REMODELING AT DIFFERENT STAGES OF CHRONIC HEART FAILURE IN PATIENTS WITH POSTINFARCTION CARDIOSCLEROSIS AND DILATED CARDIOMYOPATHY
by: V. V. Mazur, et al.
Published: (2016-01-01)

Cardiac remodeling in the acute period of Q-myocardial infarction, complicated by acute heart failure and hyperglycemia
by: V. D. Syvolap, et al.
Published: (2019-05-01)

Predictors of stress hyperglycemia in patients with acute phase of Q-wave myocardial infarction complicated by acute heart failure without diabetes history
by: N. I. Kapshytar, et al.
Published: (2018-06-01)

The effect of hyperuricemia and type 2 diabetes mellitus on the development and course of chronic heart failure
by: M. G. Kolpacheva, et al.
Published: (2025-03-01)

Carvedilol and bisoprolol effectiveness in patients with myocardial infarction and heart failure
by: A. I. Chesnikova, et al.
Published: (2008-06-01)

Prognostic value of GDF levels 15 and NTproBNP and echocardiographic parameters in patients with heart failure with preserved ejection fraction, after myocardial infarction on the background of hypertension according to the three-year observation
by: V. D. Syvolap, et al.
Published: (2015-10-01)

PLACE OF VOLUMETRIC LOAD IN ASSESSMENT OF DIASTOLIC RESERVE OF THE LEFT VENTRICLE AND IN PREDICTION OF HEART FAILURE DEVELOPMENT FOR MYOCARDIAL INFARCTION PATIENTS
by: M. T. Beyshenkulov, et al.
Published: (2016-08-01)

MILDRONATE THERAPY IN PATIENTS WITH CHRONIC HEART FAILURE, TYPE 2 DIABETES MELLITUS AND AUTONOMOUS CARDIAC NEUROPATHY
by: M. E. Statsenko, et al.
Published: (2009-06-01)

EFFECT OF ACE INHIBITOR AND RECEPTOR ANTAGONIST OF TYPE 1 ANGIOTENSIN II ON HEMODYNAMICS AND MORPHO-FUNCTIONAL PARAMETERS OF THE HEART IN PATIENTS WITH HEART FAILURE ON A BACKGROUND OF CORONARY HEART DISEASE COMBINED WITH TYPE 2 DIABETES
by: Z. V. BITAROVA, et al.
Published: (2017-09-01)

Levels of circulating catestatin in different clinical variants of coronary heart disease in patients with chronic heart failure and concomitant type 2 diabetes mellitus and obesity
by: K. M. Borovyk, et al.
Published: (2024-12-01)

Heart failure and diabetes mellitus: insight into comorbidity
by: Nina A. Petunina, et al.
Published: (2019-03-01)

CLINICAL AND ULTRASOUND PREDICTORS OF HEART FAILURE DEVELOPMENT IN PATIENTS WITH SUBACUTE MYOCARDIAL INFARCTION
by: D. Yu. Serdyukov, et al.
Published: (2012-04-01)

Selective beta-blocker bisoprolol: effectiveness and safety in complex treatment of patients with chronic heart failure and Type 2 diabetes mellitus. RAMBO-DM CHF Study results
by: Yu. V. Lapina, et al.
Published: (2008-08-01)

Risk of myocardial infarction and heart failure in gout patients: a systematic review and meta-analysis
by: Panpan Wang, et al.
Published: (2025-01-01)

Trimetazidine in coronary heart disease patients: mechanism of action and controlled trials’ results
by: L. V. Kremneva, et al.
Published: (2005-04-01)

MEXICOR IN THE COMBINATION THERAPY OF CHRONIC HEART FAILURE AND TYPE 2 DIABETES MELLITUS
by: M. E. Statsenko, et al.
Published: (2011-12-01)

Long-term carvedilol therapy effects on left ventricular remodeling and glycemia in patients with chronic heart failure and Type 2 diabetes mellitus
by: R. R. Samedov, et al.
Published: (2008-02-01)

Effect of constipation on hospitalization due to heart failure in patients after myocardial infarction: a retrospective cohort study
by: Shigeto Namiuchi, et al.
Published: (2025-05-01)

ACUTE CORONARY SYNDROME IN PATIENTS WITH DIABETES MELLITUS: ON THE WAY TO MUNICH-2008
by: I. I. Dedov, et al.
Published: (2016-01-01)

Endothelium protecting properties of taurin in chronic heart failure with type 2 diabetes
by: M. E. Stacenko, et al.
Published: (2016-04-01)

Bibliometric study and visualization of myocardial infarction combined with heart failure, 1993–2023
by: Kexin Wang, et al.
Published: (2025-08-01)

Myocardial electrical activity according to daily ECG monitoring in patients with heart failure with preserved ejection fraction and asymptomatic diastolic dysfunction
by: V. D. Syvolap, et al.
Published: (2016-01-01)

The aspirin resistance and platelets` receptors expression in chronic heart failure patients with type 2 diabetes mellitus
by: M. Yu. Kolesnyk, et al.
Published: (2014-06-01)

The role of the cardiac lymphatic system in the development and progression of heart failure and novel therapeutic approaches for its management in post-infarction cardiac remodeling
by: Yu. S. Korneva, et al.
Published: (2020-07-01)

Selective If-channel inhibitor ivabradine in the treatment of sinus tachycardia in coronary heart disease patients with acute heart failure and inferior myocardial infarction
by: S. A. Sayganov, et al.
Published: (2010-06-01)

Beta-adrenergic reactivity of erythrocytes and the progression of heart failure in patients after myocardial infarction
by: A. A. Garganeeva, et al.
Published: (2020-02-01)

Circulating hepatocyte growth factor (HGF) in patients with comorbidity of chronic heart failure, type 2 diabetes mellitus and impaired lipid metabolism
by: Tatiana Nikolaevna Kochegura, et al.
Published: (2013-06-01)

Challenges in treatment of postinfarction ventricular septal defect and heart failure
by: Mangovski Ljupčo, et al.
Published: (2015-01-01)

Glycemic control on development of chronic heart failure in patients with type 2 diabetes mellitus
by: Leonid Grigor'evich Strongin, et al.
Published: (2012-06-01)

Stem cell therapy in treatment of heart failure – a literature review
by: Igor Zydlewski, et al.
Published: (2025-03-01)

The assessment of the depressive states severity and their relationship with concomitant type 2 diabetes and obesity in patients with chronic heart failure of ischemic origin
by: K. M. Borovyk, et al.
Published: (2023-08-01)

«CLASS OF EVIDENCE IIB» FOR ACUTE HEART FAILURE: WHEN, WHO, WHY?
by: A. M. Namitokov, et al.
Published: (2019-02-01)

Immunological Regulation of Fibrosis During Heart Failure: It Takes Two to Tango
by: Vinay Kumar, et al.
Published: (2025-01-01)